CAY10594;CAY10594 Exclusive;N-[2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)ethyl]-2-naphthalenecarboxamide;2-Naphthalenecarboxamide, N-[2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)ethyl]-;N-(2-(4-Oxo-1-Phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)-2-naphthamide;CAY10594,Inhibitor,CAY 10594,CAY-10594,Phospholipase,inhibit;CAY10594, 10 mM in DMSO
CAY10594 is a potent phospholipase D2 (PLD2) inhibitor (in vitro IC50 = 140 nM; cellular IC50 = 110 nM); it significantly suppresses invasive migration of breast cancer cells in vitro and ameliorates acetaminophen-induced acute liver injury by modulating the phosphorylation of GSK-3β/JNK axis.